Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Opinion Conversations in Cardiology

All Eyes on PCI—Should Patients’ Family Members Watch Cases?

December 19, 2024

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Todd Neale

December 19, 2024

News Conference News AHA 2024

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

Todd Neale

November 18, 2024

News Conference News TCT 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Yael L. Maxwell

October 29, 2024

News Conference News TCT 2024

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

Caitlin E. Cox

October 28, 2024

Presentation NY Valves 2024

Lessons From the Initial FDA Trials

Presenter: David J. Cohen

June 06, 2024

Presentation NY Valves 2024

What would a patient consider a good outcome of intervention for symptomatic severe aortic stenosis

Presenter: David J. Cohen

June 06, 2024

News Conference News NY Valves 2024

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Michael O'Riordan

June 05, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Daily News

Event Rates, Effect Sizes Often Overestimated in Major CV Trials

Todd Neale

May 09, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

Presentation Fellows 2024

Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come

Presenter: David J. Cohen

April 12, 2024

Video

» Topical Discussion

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

December 5, 2024

Partner Content

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

December 4, 2024

Video

» Conference Wrap-Up

TCT 2024 Day 2 Wrap-Up

October 28, 2024

Video

» Interview

New Tricuspid Therapies: From Clinical Trial to Clinical Practice

June 26, 2024

Video

» Topical Discussion

Beyond the Data: Valve Interventions in Women

January 22, 2024

Advertisement

All Eyes on PCI—Should Patients’ Family Members Watch Cases?

Reimbursement Issues Seem to Be Holding Renal Denervation Back

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

Lessons From the Initial FDA Trials

What would a patient consider a good outcome of intervention for symptomatic severe aortic stenosis

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Event Rates, Effect Sizes Often Overestimated in Major CV Trials

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

TCT 2024 Day 2 Wrap-Up

New Tricuspid Therapies: From Clinical Trial to Clinical Practice

Beyond the Data: Valve Interventions in Women

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content